“We observed profound differences in the detection work up and management of chronic kidney disease suggesting suboptimal care among women,” said Juan Jesus Carrero, PharmD, PhD.
Erin Hunter
Advertisement
Articles by Erin Hunter
Fluoroquinolone could increase the risk of altered mental status and hospitalizations for older patients with advanced chronic kidney disease.
There was a 2-fold increase in risk of mortality by cardiovascular disease in the group who received hormone therapy.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Trial launches of neuromodulation therapy for erectile dysfunction after radical prostatectomy
2
PROSTOX ultra launches on US market following new data presented at ASTRO 2025
3
Published data show benefit of niraparib with AAP in HRR-deficient mCSPC
4
Rectal diazepam eases instillation of nadofaragene firadenovec in NMIBC
5
